Compare companies
Put any US companies we track side by side — SEC-sourced financials, ratios, forensic scores, and our Quality Score. Add up to four. No market price, no paywall.
INOVIO PHARMACEUTICALS, INC.
| Metric | INOVIO PHARMACEUTICALS, INC. INOHealthcare |
|---|---|
| Quality Score | 23 / 100 |
| Revenue (latest) | $65,343 |
| Net income (latest) | −$85M |
| Operating margin | −132871.3% |
| Net margin | −130000.0% |
| Return on equity | −352.5% |
| Return on assets | −114.3% |
| Return on capital (ROCE) | −283.3% |
| Debt / equity | 2.08× |
| Revenue growth (YoY) | −70.0% |
| Altman Z″ (distress) | -85.44 |
| Accruals / assets | 5.0% |
Latest reported figures from each company's own SEC filings (XBRL) plus our derived scores. Blank where a line item isn't cleanly tagged — never estimated. Descriptive factors, not advice. Open a company for its full multi-year history.